According to a new report published by Transparency
Market Research "Melatonin Market for Food & Beverages, Dietary
Supplements, Medicine and Other Applications - Global Industry Analysis, Size,
Share, Growth, Trends and Forecast, 2013 - 2019", the global demand for
the phenolic resins was valued at USD 504 million in 2012 and is expected to
reach USD 1,300.0 million in 2019, growing at a CAGR of 14.7% between 2013 and
2019.
Browse
Melatonin Market Report with Full TOC at
Melatonin has been dubbed as the "natural
wonder drug" by pundits and not without reason. Melatonin which is
generally known to be a sleep aid and a cure for primary insomnia is found to
have many other attributes. Apart from inducing sleep and alleviating jet lag,
melatonin is also a potent anti-oxidant, boosts the immune system, and is a
probable treatment for cancer, among other uses. Rising stress levels among the
general population and the dietary supplement status of melatonin in North
America are the two major driving factors for melatonin. High customer
awareness in North America coupled with the molecule's lack of side-effects
compared to other sleeping pills gives melatonin the edge in this region.
However, melatonin is not as freely available to end-users in Europe and Asia
Pacific where it is registered as a prescription drug. Although the social
demography is similar in North America and Europe, the market is considerably
limited in Europe due to the regulated status of melatonin.
Dietary supplements were the largest application
segment of melatonin and accounted for 52.5% of the global melaonin demand in
2012. This is also expected to be the fastest growing segment over the next few
years. Melatonin is marketed as a medicine in most of the countries in the
world including Europe and Asia Pacific. However as melatonin is only available
as a prescription drug, the market size is smaller compared to North America,
where it is available over the counter. Application of melatonin in food and
beverages is a new market and has witnessed high growth in the recent past and
has huge market potential as against energy drinks. However, as per the Food
and Drug Administration (FDA), the use of melatonin in food products is not
safe as it is not currently classified as a food supplement.
North America accounted for the largest share of
the global melatonin demand in 2012, followed by Europe and this trend is
expected to continue over the next few years. The Asia Pacific market has high
potential but the growth rate is expected to be relatively slower than in
Europe owing to the lack of awareness about melatonin in the general populace.
The Rest of the World (RoW) segment occupied the least market share and is
expected to exhibit the slowest growth rate among the various regions.
The report gives an in-depth analysis of the
melatonin market in terms of volume (tons) and revenue (USD million). In
addition, the report also includes current demand analysis and forecast for
each product and application segments for both global and regional level. The
regions analyzed include North America, U.S., Europe, Asia Pacific, China,
Japan and Rest of the World.
The report comprises of the following segments:
Melatonin
Market - Application Analysis
·
Dietary
supplements
·
Medicine
·
Food &
beverages
·
Others
Request
Sample Report:
The report provides a cross-sectional analysis of
the above applications segments with respect to the following regions:
Melatonin
Market - Regional Analysis
·
North America
·
U.S.
·
Europe
·
Asia-Pacific
·
China
·
Japan
·
Rest of the
World
Browse
Chemical & Materials Market Research Reports @
No comments:
Post a Comment